Netanasvir

Netanasvir
Clinical data
Trade names东卫卓; Dongweizhuo
Legal status
Legal status
  • Rx in China
Identifiers
  • Methyl N-[(1R)-2-[(2S,4S)-2-[5-[7-[2-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-3H-benzo[e]benzimidazol-7-yl]-2,3-dihydro-1H-inden-4-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC51H58N8O7
Molar mass895.074 g·mol−1
3D model (JSmol)
  • C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=C3C=CC(=C4)C5=C6CCCC6=C(C=C5)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC
  • InChI=1S/C51H58N8O7/c1-28(2)43(56-50(62)65-5)49(61)59-29(3)15-22-41(59)47-53-39-21-17-33-24-32(16-18-35(33)45(39)55-47)34-19-20-38(37-14-10-13-36(34)37)40-25-52-46(54-40)42-23-30(27-64-4)26-58(42)48(60)44(57-51(63)66-6)31-11-8-7-9-12-31/h7-9,11-12,16-21,24-25,28-30,41-44H,10,13-15,22-23,26-27H2,1-6H3,(H,52,54)(H,53,55)(H,56,62)(H,57,63)/t29-,30-,41-,42-,43-,44+/m0/s1
  • Key:SXUUQUIMLYPBSV-IVSYMLMBSA-N

Netanasvir is an antiviral drug used to treat hepatitis C virus (HCV). In China, netansavir is approved for use in combination with encofosbuvir for the treatment of adult patients with chronic HCV genotypes 1, 2, 3, or 6, who are either treatment-naive or have been previously treated with interferon.

References

  1. ↑ "Netanasvir phosphate - Sunshine Lake Pharma". Adis Insight. Springer Nature Switzerland AG.
  2. ↑ "Netanasvir Phosphate Capsules Approved for Marketing by China NMPA". National Medical Products Administration. 2025-06-11.